Furthermore, the results of our IHC analysis also indicate that primary tumours from patients who eventually developed brain metastasis (n = 6) expressed significantly higher IL-1β compared to the tumours from overall metastasis-free patients with the similar clinical grades (n = 11; Fig 2F and Supporting Information Fig S2C). This evidence concerns the gene IL1B and neoplasm.